Cart
sales@molnova.com
Tyrphostin AG 1296
CAS No. 146535-11-7
Tyrphostin AG 1296 ( 6,7-Dimethoxy-3-phenylquinoxaline )
Catalog No. M17312 CAS No. 146535-11-7
Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 80 | In Stock |
|
| 10MG | 138 | In Stock |
|
| 25MG | 285 | In Stock |
|
| 50MG | 441 | In Stock |
|
| 100MG | 651 | In Stock |
|
| 500MG | 1368 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrphostin AG 1296
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.
-
Description6,7-Dimethoxy-3-phenylquinoxaline is an ATP-competitive inhibitor of receptor kinase.
-
Synonyms6,7-Dimethoxy-3-phenylquinoxaline
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorPDGFR
-
Research AreaCardiovascular Disease|Inflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number146535-11-7
-
Formula Weight266.29
-
Molecular FormulaC16H14N2O2
-
Purity98%
-
Solubility——
-
SMILESCOc1cc2nc(cnc2cc1OC)c3ccccc3
-
Chemical Name6,7-Dimethoxy-3-phenylquinoxaline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kovalenko M, et al. Cancer Res, 1994, 54(23), 6106-6114.
molnova catalog
related products
-
Epimedin B
Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.
-
CO-1686
A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.
-
CK-101
CK-101 (RX-518) is a novel potent, mutant-selective, irreversible, orally available EGFR inhibitor, overcomes T790M-mediated resistance in NSCLC.
